Gilead’s Trodelvy fails to extend survival in lung cancer study, prompting selloff zbecker Mon, 01/22/2024 – 09:29 More: Gilead's Trodelvy fails to extend survival in lung cancer study, prompting selloff Source: fierce
read moreApproximately one in five children will be hospitalised to treat measles More: NHS catch up campaign launched for missed MMR vaccines Source: News
read moreApproximately 48,000 deaths in the UK occur from sepsis every year More: Virtual reality training to help NHS doctors spot signs of sepsis Source: News
read moreFDA slaps boxed warning on Amgen’s osteoporosis drug Prolia kdunleavy Fri, 01/19/2024 – 15:18 More: FDA slaps boxed warning on Amgen's osteoporosis drug Prolia Source: fierce
read moreBristol Myers shows power of Opdivo-Yervoy combo in first-line colorectal cancer subset aliu Fri, 01/19/2024 – 11:18 More: Bristol Myers shows power of Opdivo-Yervoy combo in first-line colorectal cancer subset Source: fierce
read moreAstraZeneca adds to rare blood disease portfolio with world-first Voydeya approval in Japan zbecker Fri, 01/19/2024 – 10:54 More: AstraZeneca adds to rare blood disease portfolio with world-first Voydeya approval in Japan Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals